Preclinical Characterization of the Anti-Leukemia Activity of the CD123 Antibody-Drug Conjugate, Pivekimab Sunirine (IMGN632)

被引：0
|
作者：
Cole, Frances M. [1 ]
Laszlo, George S. [2 ]
Lunn-Halbert, Margaret C. [1 ]
Kehret, Allie R. [1 ]
Zweidler-McKay, Patrick A. [3 ]
Rodriguez-Arboli, Eduardo [1 ,4 ]
Wu, David [5 ]
Nyberg, Kyle E. [1 ]
Li, Junyang [1 ]
Lim, Sheryl Y. T. [1 ]
Lakshmikanthan, Sribalaji [3 ]
Walter, Roland B. [6 ,7 ,8 ]
机构：
[1] Fred Hutchinson Canc Ctr, Translat Sci & Therapeut Div, Seattle, WA USA
[2] Fred Hutchinson Canc Ctr, 1100 Fairview Ave North, Seattle, WA USA
[3] ImmunoGen Inc, Waltham, MA USA
[4] Univ Seville, Hosp Univ Virgen del Rocio, Dept Hematol, Inst Biomed Sevilla, Seville, Spain
[5] Univ Washington, Hematopathol, Seattle, WA USA
[6] Fred Hutchinson Canc Ctr, Seattle, WA USA
[7] Univ Washington, Dept Med, Div Hematol & Oncol, Seattle, WA USA
[8] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-200907
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2751 / 2751
页数：1
相关论文
共 50 条
  • [31] Synergistic antileukemic activity of the antibody-drug conjugate (IMGN779) combined with PARP inhibition in preclinical human acute myeloid leukemia models
    Fritz, Claire
    Portwood, Scott M.
    Adams, Julie
    Wang, Eunice S.
    CANCER RESEARCH, 2018, 78 (13)
  • [32] Development of Highly Optimized Antibody-Drug Conjugates against CD33 and CD123 for Acute Myeloid Leukemia
    Han, Yoon-Chi
    Kahler, Jennifer
    Piche-Nicholas, Nicole
    Hu, Wenyue
    Thibault, Stephane
    Jiang, Fan
    Leal, Mauricio
    Katragadda, Madan
    Maderna, Andreas
    Dushin, Russell
    Prashad, Nadira
    Charati, Manoj B.
    Clark, Tracey
    Tumey, L. Nathan
    Tan, Xingzhi
    Giannakou, Andreas
    Rosfjord, Edward
    Gerber, Hans-Peter
    Tchistiakova, Lioudmila
    Loganzo, Frank
    O'Donnell, Christopher J.
    Sapra, Puja
    CLINICAL CANCER RESEARCH, 2021, 27 (02) : 622 - 631
  • [33] Preclinical Development of an Anti-CD38 Antibody-Drug Conjugate for Treatment of Hematological Malignancies
    Li, Lingna
    Tong, Wenyong
    Lau, Megan
    Fells, Katherine
    Zhu, Tong
    Sun, Yingqing
    Kovacs, Ernest
    Khasanov, Alisher
    Yan, Zheng
    Deng, Dalun
    Takeshita, Ken
    Kaufmann, Gunnar F.
    Ji, Henry
    Li, Hui
    Zhang, Hong
    BLOOD, 2019, 134
  • [34] Combining IMGN779, a Novel Anti-CD33 Antibody-Drug Conjugate (ADC), with the PARP Inhibitor, Olaparib, Results in Enhanced Anti-Tumor Activity in Preclinical Acute Myeloid Leukemia (AML) Models
    Portwood, Scott
    Puchalski, Robert A.
    Walker, Russell M.
    Wang, Eunice S.
    BLOOD, 2016, 128 (22)
  • [35] Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid Leukemia
    van der Lee, Miranda
    van Achtenberg, Tanja
    Brouwers-Vos, Annet
    van der Vleuten, Monique
    Kappers, Wendy
    Verheijden, Gijs
    Huls, Geert A.
    van Wigcheren, Glenn
    Ubink, Ruud
    Sesink, Aloys
    MacInnes, Alyson
    Schuringa, Jan Jacob
    Dokter, Wim
    BLOOD, 2023, 142
  • [36] Anti-Leukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody-Conjugate in Acute Myeloid Leukemia
    Han, Lina
    Rowinsky, Eric
    Brooks, Christopher
    Zal, Tomasz
    Zal, M. Anna
    Burks, Jared K.
    Zhou, Jin
    Ciurea, Stefan O.
    Alatrash, Gheath
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Andreeff, Michael
    Ravandi, Farhad
    Konopleva, Marina
    BLOOD, 2014, 124 (21)
  • [37] Preclinical studies targeting CD74 with STRO-001 antibody-drug conjugate in acute leukemia
    Le, Quy
    Tang, Thao
    Leonti, Amanda
    Castro, Sommer
    McKay, Cyd Nourigat
    Perkins, LaKeisha
    Pardo, Laura
    Kirkey, Danielle
    Hylkema, Tiffany
    Call, Lindsey
    Manselle, Makia
    Abrahams, Cristina
    Bedard, Kristin
    Molina, Arturo
    Brodersen, Lisa Eidenshinck
    Loken, Michael R.
    Tarlock, Katherine
    Meshinchi, Soheil
    Loeb, Keith R.
    BLOOD ADVANCES, 2023, 7 (09) : 1666 - 1670
  • [38] Preclinical characterization of IMAB362-vcMMAE, an anti-CLDN18.2 antibody-drug conjugate
    Kreuzberg, M.
    Mitnacht-Kraus, R.
    Sahin, U.
    Tuereci, Oe.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenografts
    Jones, Luke
    McCalmont, Hannah
    Evans, Kathryn
    Mayoh, Chelsea
    Kurmasheva, Raushan T.
    Billups, Catherine A.
    Houghton, Peter J.
    Smith, Malcolm A.
    Lock, Richard B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (08)
  • [40] Preclinical Mechanistic Studies Investigating Neutrophil and Lymphoid Cell Depletion By IMGN529, a CD37-Targeting Antibody-Drug Conjugate (ADC)
    Deckert, Jutta
    Ponte, Jose F.
    Coccia, Jennifer A.
    Lanieri, Leanne
    Chicklas, Sharon
    Yi, Yong
    Watkins, Krystal
    Ruiz-Soto, Rodrigo
    Romanelli, Angela
    Lutz, Robert J.
    BLOOD, 2014, 124 (21)
12345